glp-1 eating disorder Receptor Agonists and Research to Treat Overeating and Substance Use Disorders GLP-1 medications are changing medicine

This Fe-containing homotetrameric CAT is responsible for the catalysation of H 2 O 2 overproduced during light respiration or photorespiration in peroxisomes, H 2 O 2 produced during -oxidation of fatty acids in glyoxysomes or H 2 O 2 produced by SOD (Zandi and Schnug 2022)

Another RCT examined the effect of B1 (300 mg/d), B6 (80 mg/d), B9 (2mg/d), B12 (500 g/d) supplements and B-complex for 12 weeks on patients with migraine, compared with the placebo

Hachem JP, Roelandt T, Schurer N, Pu X, Fluhr J, Giddelo C, Man MQ, Crumrine D, Roseeuw D, Feingold KR, Mauro T, Elias PM (2010)

Understanding how these medications work - and what happens when treatment ends - can help patients create a smarter long-term strategy for weight management